US Patent 11186650 Anti-CD3 antibodies and methods of use
Patent 11186650 was granted and assigned to Genentech on November, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 27, 2018
Date of Patent
November 30, 2021
Patent Applicant
Patent Application Number
16144686
Patent Inventor Names
Xiaocheng Chen
0
Mark S. Dennis
0
Mary A. Mathieu
0
Robert F. Kelley
0
Allen J. Ebens, Jr.
0
Liping L. Sun
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11186650 Anti-CD3 antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.